Nuvectis Pharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $20.4M
Liabilities Breakdown FY2022
Total Liabilities: $6.2M
Asset Breakdown
Total Assets: $20.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $20.0M | 98.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $412.0K | 2.0% |
Liabilities Breakdown
Total Liabilities: $6.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.9M | 47.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $3.3M | 53.0% |